Cumberland Pharmaceuticals Inc (NAS:CPIX)
$ 1.28 0.03 (2.4%) Market Cap: 18.04 Mil Enterprise Value: 21.85 Mil PE Ratio: 0 PB Ratio: 0.68 GF Score: 51/100

Q4 2019 Cumberland Pharmaceuticals Inc Earnings Call Transcript

Mar 18, 2020 / 08:30PM GMT
Release Date Price: $3.53 (-7.11%)
Operator

Thank you for joining the Cumberland Pharmaceuticals Fourth Quarter 2019 Financial Results -- Financial Report and Company Update. Please note that this conference call is being recorded at the company's request and will be archived on Cumberland's website for 1 week from today's date.

Now I would like to introduce Erin Gull, who is responsible for Corporate Relations at Cumberland. Erin, please go ahead.

Erin Smith Gull
Cumberland Pharmaceuticals Inc. - Senior Corporate Relations Associate

Good afternoon. Today, we issued a press release featuring our fourth quarter and full year 2019 financial results and company update. You can find that release, including all the related financial tables on our website at www.cumberlandpharma.com.

Additionally, our call today may contain forward-looking statements within the meaning of the Private Securities Reform Act of 1995. Because the statements in today's call reflects the company's current views and expectations concerning

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot